PECAM1 and gastric neoplasm: Although toluidine-staining confirmed that clodrosome treatment did not reduce the abundance of submucosal mast cells, gastric tumors and adjacent submucosa from the clodrosome cohort revealed reduced density of CD31-positive microvessels (Fig. 4e and Supplementary Fig. 4a).